Ono Pharmaceutical Co., Ltd - Strategy, SWOT and Corporate Finance Report
Summary
Ono Pharmaceutical Co., Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Ono Pharmaceutical Co., Ltd. (Ono or 'the company') is a pharmaceutical company that manufactures and sells pharmaceuticals and diagnostic reagents with focus on prescription pharmaceuticals. The company offers products in various forms such as capsules, tablets, injections, patches, dry syrup and intravenous infusion. It offers its products under Opdivo, Glactiv, Forxiga, Recalbon, Parsabiv, Rivastach, Onoact, Staybla, Opalmon, Onon, Staybla, Orencia and Foipan brand names. It offers these products for the treatment of chronic pancreatitis, postoperative reflux esophagitis, type 2 diabetes, peripheral circulatory disorder, overactive bladder, osteoporosis, bronchial asthma, Alzheimer’s disease, rheumatoid arthritis and allergic rhinitis, among others. Ono has business presence across the Asia, Europe and the US. The company is headquartered in Chuo-ku, Osaka, Japan
Scope
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook